Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
An unusual case of neurobrucellosis presenting as demyelination disorder.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Regulatory T-cell vaccination independent of auto-antigen.
Mode of action and clinical studies with alemtuzumab.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
Update on neurodegeneration with brain iron accumulation.
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Time-Lapse Imaging of Glial-Axonal Interactions.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
EAE is not a useful model for demyelinating disease.
The temporal dynamics of visual processing in multiple sclerosis.
Cognitive evaluation by tasks in a virtual reality environment in multiple sclerosis.
Education attenuates the negative impact of traumatic brain injury on cognitive status.
Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.

Pages